BR112013029208A2 - método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto - Google Patents
método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, compostoInfo
- Publication number
- BR112013029208A2 BR112013029208A2 BR112013029208A BR112013029208A BR112013029208A2 BR 112013029208 A2 BR112013029208 A2 BR 112013029208A2 BR 112013029208 A BR112013029208 A BR 112013029208A BR 112013029208 A BR112013029208 A BR 112013029208A BR 112013029208 A2 BR112013029208 A2 BR 112013029208A2
- Authority
- BR
- Brazil
- Prior art keywords
- oligosaccharides
- derivatives
- preparing
- compound
- human milk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/075—Benzo[b]pyran-2-ones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0114—Lacto-N-biosidase (3.2.1.140)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Mycology (AREA)
- Pediatric Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11166135 | 2011-05-13 | ||
PCT/IB2012/051314 WO2012127410A1 (en) | 2011-03-18 | 2012-03-19 | Synthesis of new fucose-containing carbohydrate derivatives |
PCT/IB2012/052400 WO2012156897A1 (en) | 2011-05-13 | 2012-05-14 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013029208A2 true BR112013029208A2 (pt) | 2017-02-14 |
Family
ID=47176363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013029208A BR112013029208A2 (pt) | 2011-05-13 | 2012-05-14 | método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto |
Country Status (12)
Country | Link |
---|---|
US (1) | US9234225B2 (pt) |
EP (1) | EP2707493A4 (pt) |
JP (1) | JP2014513985A (pt) |
KR (1) | KR20140036227A (pt) |
CN (1) | CN103562401A (pt) |
AU (1) | AU2012257395A1 (pt) |
BR (1) | BR112013029208A2 (pt) |
CA (1) | CA2835986A1 (pt) |
IL (1) | IL229048A0 (pt) |
MX (1) | MX2013013028A (pt) |
RU (1) | RU2013155452A (pt) |
WO (1) | WO2012156897A1 (pt) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140001198A (ko) | 2010-07-16 | 2014-01-06 | 글리콤 에이/에스 | 신규 시알로올리고당 유도체들의 합성 |
CA2830025A1 (en) * | 2011-03-18 | 2012-09-27 | Glycom A/S | Synthesis of new fucose-containing carbohydrate derivatives |
WO2013190529A1 (en) * | 2012-06-22 | 2013-12-27 | Glycom A/S | Glycosylated galactosyl disaccharddes, methods for their production and their use in consumable products |
EP2864344A4 (en) * | 2012-06-22 | 2015-12-23 | Glycom As | GALACTOSYL GLYCOSYLATED DISACCHARIDES, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN CONSUMABLE PRODUCTS |
EP2931737A4 (en) * | 2012-12-14 | 2016-11-16 | Glycom As | MIXTURE FROM FUCOSYLATE LACTOSES |
GB201306689D0 (en) | 2013-04-12 | 2013-05-29 | Glycom As | Synthesis of sialylated/fucosylated human milk oligosaccharides |
US20160113952A1 (en) | 2013-05-22 | 2016-04-28 | Glycom As | Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal |
US10364449B2 (en) | 2013-09-06 | 2019-07-30 | Glycom A/S | Fermentative production of oligosaccharides |
PL2845905T3 (pl) | 2013-09-10 | 2021-09-27 | Chr. Hansen HMO GmbH | Wytwarzanie oligosacharydów |
EP2857410A1 (en) * | 2013-10-04 | 2015-04-08 | Jennewein Biotechnologie GmbH | Process for purification of 2´-fucosyllactose using simulated moving bed chromatography |
MY186844A (en) | 2014-07-09 | 2021-08-25 | Cadena Bio Inc | Oligosaccharide compositions and methods for producing thereof |
US10415021B2 (en) | 2014-10-24 | 2019-09-17 | Glycom A/S | Mutated fucosidase |
PL3209673T5 (pl) | 2014-10-24 | 2023-10-23 | Glycom A/S | Mieszaniny hmo |
EP3212197A4 (en) | 2014-10-29 | 2018-07-11 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
US11040049B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
US11040050B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
ES2856053T3 (es) | 2014-10-29 | 2021-09-27 | Glycom As | Composición sintética y procedimiento para promover la cicatrización de la mucosa |
US10500221B2 (en) * | 2014-12-05 | 2019-12-10 | Glycom A/S | Crystalline difucosyllactose |
US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
US10881674B2 (en) | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
WO2016091265A1 (en) | 2014-12-08 | 2016-06-16 | Glycom A/S | Synthetic composition for treating metabolic disorders |
US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
CN112515178A (zh) * | 2015-01-26 | 2021-03-19 | 卡德纳生物股份有限公司 | 用于营养组合物的寡糖组合物和其制造方法 |
PT3354282T (pt) | 2015-01-26 | 2021-03-18 | Kaleido Biosciences Inc | Produtos terapêuticos de glicanos e seus métodos relacionados |
JP6722697B2 (ja) * | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
CN115300517A (zh) * | 2015-03-31 | 2022-11-08 | 格礼卡姆股份公司 | 包含3’-o-唾液乳糖的人乳寡糖的混合物 |
CA2983236A1 (en) | 2015-04-23 | 2016-10-27 | Kaleido Biosciences, Inc. | Glycan therapeutics and methods of treatment |
PL3307752T3 (pl) | 2015-06-09 | 2021-11-02 | Glycom A/S | Mieszaniny trójskładnikowe 6’-sl, lnnt i lst c |
EP3349763B1 (en) | 2015-09-14 | 2021-08-11 | Glycom A/S | Composition for use in microbiota modulation |
EP3368046B1 (en) | 2015-10-28 | 2022-07-27 | Glycom A/S | Synthetic composition and method for modulating brain function and behaviour |
EP3368047B1 (en) | 2015-10-28 | 2023-04-26 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
WO2017084673A1 (en) | 2015-11-17 | 2017-05-26 | Glycom A/S | Synthetic Composition for Treating Antibiotic Associated Complications |
US10857168B2 (en) | 2016-02-24 | 2020-12-08 | Glycom A/S | Synthetic composition for microbiota modulation |
KR101731263B1 (ko) * | 2016-04-25 | 2017-05-02 | 서울대학교 산학협력단 | 코리네박테리움 글루타미쿰을 이용한 2'-푸코실락토오스의 생산방법 |
WO2017190754A1 (en) | 2016-05-05 | 2017-11-09 | Glycom A/S | Composition comprising hmos for the treatment of non-infectious diarrhoea |
WO2017190755A1 (en) | 2016-05-05 | 2017-11-09 | Glycom A/S | Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain |
WO2017198276A1 (en) | 2016-05-19 | 2017-11-23 | Glycom A/S | Synthetic composition |
WO2017221208A1 (en) * | 2016-06-24 | 2017-12-28 | Glycom A/S | Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infections |
WO2018031734A1 (en) * | 2016-08-10 | 2018-02-15 | University Of Maryland, College Park | DESIGNER α1,6-FUCOSIDASE MUTANTS ENABLE DIRECT CORE FUCOSYLATION OF INTACT N-GLYCOPEPTIDES AND N-GLYCOPROTEINS |
US11278558B2 (en) | 2017-03-01 | 2022-03-22 | Glycom A/S | Synthetic composition for microbiota modulation |
US11291677B2 (en) | 2017-05-09 | 2022-04-05 | Glycom A/S | Synthetic composition for microbiota modulation |
EP3630124A4 (en) | 2017-05-24 | 2021-02-24 | Glycom A/S | SYNTHETIC COMPOSITION CONSISTING OF OLIGOSACCHARIDES AND ITS USE IN MEDICAL TREATMENT |
US11541067B2 (en) | 2017-05-24 | 2023-01-03 | Glycom A/S | HMO compositions and methods for reducing detrimental proteolytic metabolites |
US11142541B2 (en) | 2017-06-30 | 2021-10-12 | Glycom A/S | Purification of oligosaccharides |
EP3672600A4 (en) | 2017-08-21 | 2021-05-19 | Glycom A/S | SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS |
WO2019087140A1 (en) | 2017-11-02 | 2019-05-09 | Glycom A/S | One or more hmos for reducing or preventing fatigue and/or improving focus or concentration |
JP7327724B2 (ja) | 2017-11-30 | 2023-08-16 | グリコム・アクティーゼルスカブ | 小麦過敏症を処置するためのhmoの混合物 |
US11602545B2 (en) | 2017-12-05 | 2023-03-14 | Glycom A/S | Human milk oligosaccharides for treating migraine |
US11304966B2 (en) | 2017-12-22 | 2022-04-19 | Glycom A/S | Composition comprising HMOs for preventing or reducing nociception |
JP2021526143A (ja) | 2018-05-31 | 2021-09-30 | グリコム・アクティーゼルスカブGlycom A/S | 自己免疫疾患を処置するためのhmoの混合物 |
SG11202104207TA (en) * | 2018-11-08 | 2021-05-28 | Kaleido Biosciences Inc | Oligosaccharide compositions and methods of use thereof |
CN113194960A (zh) | 2018-12-19 | 2021-07-30 | 格礼卡姆股份公司 | 用于治疗使用低fodmap饮食的人的组合物和方法 |
EP3670662A1 (en) | 2018-12-20 | 2020-06-24 | Basf Se | Enzymatic hexosaminidation of lactose |
CN110483652A (zh) * | 2019-06-11 | 2019-11-22 | 中国农业大学 | 一种人乳寡糖及其在制备用于通过缓解肠道缺氧损伤而治疗或预防nec的药物中的用途 |
CN114350640B (zh) * | 2019-12-13 | 2023-09-08 | 中国科学院天津工业生物技术研究所 | 一株表达几丁质酶重组菌的构建及高酶活突变体的筛选 |
CN116249781A (zh) * | 2020-08-10 | 2023-06-09 | 因比奥斯公司 | 在细胞中的含有GlcNAc的生物产品的产生 |
CN112795583A (zh) * | 2020-11-16 | 2021-05-14 | 上海大学 | 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法 |
WO2022223430A1 (en) | 2021-04-19 | 2022-10-27 | Dsm Ip Assets B.V. | A composition of enzymes and human milk oligosaccharides |
DK202200588A1 (en) | 2022-06-20 | 2024-02-23 | Dsm Ip Assets Bv | Mixture of fucosylated HMOs |
WO2024042235A1 (en) | 2022-08-25 | 2024-02-29 | Dsm Ip Assets B.V. | Hybrid method for producing complex hmos |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032492A1 (en) | 1995-04-11 | 1996-10-17 | Cytel Corporation | Improved enzymatic synthesis of oligosaccharides |
IT1290071B1 (it) * | 1997-03-13 | 1998-10-19 | Cooperativa Centro Ricerche Po | Sintesi completamente transglicolica di oligosaccaridi ramificati |
US6323008B1 (en) | 1997-08-14 | 2001-11-27 | Neose Technologies, Inc. | Methods for producing sialyloligosaccharides in a dairy source |
EP1425408A4 (en) * | 2001-08-17 | 2004-11-10 | Neose Technologies Inc | CHEMICAL-ENZYMATIC SYNTHESIS OF SIALYL OLIGOSACCHARIDES |
EP2497478A3 (en) | 2003-12-05 | 2012-11-07 | Children's Hospital Medical Center | Oligosaccaride compositions and use thereof in the treatment of infection |
CN105330705A (zh) | 2010-02-19 | 2016-02-17 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
KR20140001198A (ko) | 2010-07-16 | 2014-01-06 | 글리콤 에이/에스 | 신규 시알로올리고당 유도체들의 합성 |
CA2830025A1 (en) | 2011-03-18 | 2012-09-27 | Glycom A/S | Synthesis of new fucose-containing carbohydrate derivatives |
-
2012
- 2012-05-14 AU AU2012257395A patent/AU2012257395A1/en not_active Abandoned
- 2012-05-14 CA CA2835986A patent/CA2835986A1/en not_active Abandoned
- 2012-05-14 KR KR1020137032962A patent/KR20140036227A/ko not_active Application Discontinuation
- 2012-05-14 JP JP2014510919A patent/JP2014513985A/ja active Pending
- 2012-05-14 US US14/117,348 patent/US9234225B2/en not_active Expired - Fee Related
- 2012-05-14 CN CN201280023643.7A patent/CN103562401A/zh active Pending
- 2012-05-14 BR BR112013029208A patent/BR112013029208A2/pt not_active IP Right Cessation
- 2012-05-14 WO PCT/IB2012/052400 patent/WO2012156897A1/en active Application Filing
- 2012-05-14 RU RU2013155452/10A patent/RU2013155452A/ru not_active Application Discontinuation
- 2012-05-14 EP EP12785846.2A patent/EP2707493A4/en not_active Withdrawn
- 2012-05-14 MX MX2013013028A patent/MX2013013028A/es not_active Application Discontinuation
-
2013
- 2013-10-24 IL IL229048A patent/IL229048A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2014513985A (ja) | 2014-06-19 |
MX2013013028A (es) | 2013-12-02 |
IL229048A0 (en) | 2013-12-31 |
EP2707493A1 (en) | 2014-03-19 |
US9234225B2 (en) | 2016-01-12 |
EP2707493A4 (en) | 2014-10-08 |
WO2012156897A1 (en) | 2012-11-22 |
AU2012257395A1 (en) | 2013-12-12 |
US20140234912A1 (en) | 2014-08-21 |
RU2013155452A (ru) | 2015-06-20 |
CA2835986A1 (en) | 2012-11-22 |
CN103562401A (zh) | 2014-02-05 |
KR20140036227A (ko) | 2014-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013029208A2 (pt) | método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto | |
BR112013029203A2 (pt) | método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano | |
BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
BR112014010179A8 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
BR112014003681A8 (pt) | composto, composição farmacêutica, produto de combinação farmacêutica, uso de um composto, e, método para tratar doenças ou condições | |
BR112014003802A2 (pt) | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento | |
ZA201503753B (en) | Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof | |
BR112013026410A2 (pt) | compostos antimicrobianos e métodos de preparação e uso dos mesmos | |
BR112014001346A8 (pt) | composto nanotransportador, método, composto farmacêutico e uso de um composto | |
BR112012026570A2 (pt) | composto, composição farmacêutica, uso de um composto, método para o tratamento de um indíviduo e produto combinado | |
BRPI0922174A2 (pt) | preparação farmacêutica, uso de uma preparação, e, método para preparar uma preparação farmacêutica | |
BR112012029227A2 (pt) | processo para a preparação de um conjunto quiral, composto quiral, composição, composição farmacêutica, uso de uma composição, método de tratamento ou prevenção e uso de um composto | |
BR112015015758A2 (pt) | dispersão sólida, formulação sólida, método de preparo de uma dispersão sólida, preparação farmacêutica e uso de uma dispersão sólida | |
ES2603028T8 (es) | Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos | |
BR112014032510A2 (pt) | composto, composição farmacêutica, método para tratar ou prevenir uma doença ou desordem, e, uso de um composto. | |
BR112014001991A2 (pt) | certos inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso dos mesmos | |
BR112012031981A2 (pt) | composição aquosa de ingrediente ativo, processo, uso, método para controlar fungos fitopatogênicos e semente | |
BR112014006420A2 (pt) | compostos, composição farmacêutica, uso de um composto e mètodo para o tratamento ou profilaxia | |
BR112015008908A2 (pt) | uso de ivermectina e seus derivados e método para desenhar e sintetizar novos derivados | |
ITMI20110480A1 (it) | Procedimento per la preparazione di lapatinib e suoi sali | |
EP3056269A4 (en) | Supported catalyst, preparation method therefor and use thereof, and method for preparation of isobutylene from halomethane | |
BR112014008241A2 (pt) | composto, composição farmacêutica, métodos para tratar, controlar, retardar ou prevenir doenças e distúrbios, e para preparar um composto, e, uso de um composto | |
BR112014016736A8 (pt) | composto, composição farmacêutica, método para tratamento, uso de um composto e invenção | |
BR112013015085A2 (pt) | composição farmacêutica, método para preparar uma composição, e, uso de composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |